483 InvaGen Pharmaceuticals Jan 2012

483 InvaGen Pharmaceuticals Jan 2012

Neil Bonzagni FDA$119.00 - Available Now

FDA investigators audited the InvaGen Pharmaceuticals - Hauppauge, NY, United States facility and issued inspectional observations (via FDA 483) on 06 Jan 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Jan 2012
  • Location: Hauppauge, United States
  • FEI: 3003950641
Add To Cart